AAPL325.07-8.67 (-2.60%) ▼|ABBV254.15-0.34 (-0.13%) ▼|ABT101.52+0.84 (+0.83%) ▲|ACN144.29+0.72 (+0.50%) ▲|ADBE233.26-3.99 (-1.68%) ▼|AMAT535.90+6.24 (+1.18%) ▲|AMD516.66+20.90 (+4.22%) ▲|AMGN366.67+0.38 (+0.10%) ▲|AMT168.56-1.51 (-0.89%) ▼|AMZN252.41+5.18 (+2.10%) ▲|AVGO382.87+12.05 (+3.25%) ▲|AXP353.38-1.98 (-0.56%) ▼|BA210.38-3.65 (-1.71%) ▼|BAC60.76-0.52 (-0.84%) ▼|BKNG179.92-1.77 (-0.97%) ▼|BLK1,067.27-4.94 (-0.46%) ▼|BMY60.85+0.11 (+0.18%) ▲|BNY157.32+0.19 (+0.12%) ▲|BRK-B490.40-0.51 (-0.10%) ▼|C129.90+0.54 (+0.42%) ▲|CAT869.29-9.37 (-1.07%) ▼|CL91.55-0.90 (-0.97%) ▼|CMCSA23.88+0.09 (+0.36%) ▲|COF208.21+0.18 (+0.08%) ▲|COP116.09+1.38 (+1.20%) ▲|COST937.76-3.12 (-0.33%) ▼|CRM172.73+1.96 (+1.15%) ▲|CSCO111.95+0.01 (+0.01%) ▲|CVS107.40-0.07 (-0.07%) ▼|CVX189.54+2.16 (+1.15%) ▲|DE587.37-9.87 (-1.65%) ▼|DHR201.82-2.02 (-0.99%) ▼|DIS96.73-0.95 (-0.97%) ▼|DUK125.34+0.33 (+0.26%) ▲|EMR137.08-2.47 (-1.77%) ▼|FDX306.94-6.04 (-1.93%) ▼|GD373.71+5.13 (+1.39%) ▲|GE344.60-4.23 (-1.21%) ▼|GEV1,065.93+8.09 (+0.76%) ▲|GILD133.53-0.75 (-0.56%) ▼|GM76.15+0.08 (+0.11%) ▲|GOOG355.32+9.20 (+2.66%) ▲|GOOGL355.56+8.79 (+2.53%) ▲|GS1,060.90-4.32 (-0.41%) ▼|HD333.69-5.18 (-1.53%) ▼|HON227.06+2.04 (+0.91%) ▲|IBM215.02+2.35 (+1.11%) ▲|INTC99.25+4.21 (+4.43%) ▲|INTU292.57+1.48 (+0.51%) ▲|ISRG351.12+5.70 (+1.65%) ▲|JNJ251.11-1.93 (-0.76%) ▼|JPM340.27-0.83 (-0.24%) ▼|KO81.53-0.03 (-0.04%) ▼|LIN513.98+0.76 (+0.15%) ▲|LLY1,167.20-11.92 (-1.01%) ▼|LMT512.63+3.86 (+0.76%) ▲|LOW204.91-3.82 (-1.83%) ▼|LRCX312.30-1.01 (-0.32%) ▼|MA546.40+2.80 (+0.52%) ▲|MCD267.24-0.47 (-0.18%) ▼|MDLZ59.79-1.22 (-1.99%) ▼|MDT83.66+0.46 (+0.55%) ▲|META647.51+1.50 (+0.23%) ▲|MMM160.89+1.05 (+0.66%) ▲|MO74.24+0.03 (+0.04%) ▲|MRK125.68-1.82 (-1.43%) ▼|MS211.96-3.54 (-1.64%) ▼|MSFT400.05+6.23 (+1.58%) ▲|MU899.47+50.52 (+5.95%) ▲|NEE88.12-0.68 (-0.77%) ▼|NFLX67.95-1.00 (-1.45%) ▼|NKE43.36-0.40 (-0.91%) ▼|NOW103.69+0.45 (+0.44%) ▲|NVDA205.66+2.85 (+1.41%) ▲|ORCL122.68-3.73 (-2.95%) ▼|PEP134.92-2.21 (-1.61%) ▼|PFE24.89-0.17 (-0.66%) ▼|PG149.43-0.56 (-0.37%) ▼|PLTR135.23+2.85 (+2.15%) ▲|PM192.02-0.97 (-0.50%) ▼|QCOM172.88+1.10 (+0.64%) ▲|RTX196.71+3.20 (+1.65%) ▲|SBUX106.09+0.60 (+0.57%) ▲|SCHW100.49-1.07 (-1.05%) ▼|SO95.43+0.13 (+0.14%) ▲|SPG230.04+1.34 (+0.59%) ▲|T21.83+0.02 (+0.09%) ▲|TMO526.68-5.81 (-1.09%) ▼|TMUS194.42+1.99 (+1.03%) ▲|TSLA375.30-5.54 (-1.45%) ▼|TXN289.55+5.53 (+1.95%) ▲|UBER72.23-0.23 (-0.32%) ▼|UNH422.09-4.00 (-0.94%) ▼|UNP300.40-1.35 (-0.45%) ▼|UPS113.72-4.00 (-3.40%) ▼|USB63.27+0.13 (+0.21%) ▲|V359.07+0.51 (+0.14%) ▲|VZ43.48-0.12 (-0.26%) ▼|WFC86.96-0.55 (-0.63%) ▼|WMT113.99-0.25 (-0.22%) ▼|XOM148.37+1.01 (+0.68%) ▲|AAPL325.07-8.67 (-2.60%) ▼|ABBV254.15-0.34 (-0.13%) ▼|ABT101.52+0.84 (+0.83%) ▲|ACN144.29+0.72 (+0.50%) ▲|ADBE233.26-3.99 (-1.68%) ▼|AMAT535.90+6.24 (+1.18%) ▲|AMD516.66+20.90 (+4.22%) ▲|AMGN366.67+0.38 (+0.10%) ▲|AMT168.56-1.51 (-0.89%) ▼|AMZN252.41+5.18 (+2.10%) ▲|AVGO382.87+12.05 (+3.25%) ▲|AXP353.38-1.98 (-0.56%) ▼|BA210.38-3.65 (-1.71%) ▼|BAC60.76-0.52 (-0.84%) ▼|BKNG179.92-1.77 (-0.97%) ▼|BLK1,067.27-4.94 (-0.46%) ▼|BMY60.85+0.11 (+0.18%) ▲|BNY157.32+0.19 (+0.12%) ▲|BRK-B490.40-0.51 (-0.10%) ▼|C129.90+0.54 (+0.42%) ▲|CAT869.29-9.37 (-1.07%) ▼|CL91.55-0.90 (-0.97%) ▼|CMCSA23.88+0.09 (+0.36%) ▲|COF208.21+0.18 (+0.08%) ▲|COP116.09+1.38 (+1.20%) ▲|COST937.76-3.12 (-0.33%) ▼|CRM172.73+1.96 (+1.15%) ▲|CSCO111.95+0.01 (+0.01%) ▲|CVS107.40-0.07 (-0.07%) ▼|CVX189.54+2.16 (+1.15%) ▲|DE587.37-9.87 (-1.65%) ▼|DHR201.82-2.02 (-0.99%) ▼|DIS96.73-0.95 (-0.97%) ▼|DUK125.34+0.33 (+0.26%) ▲|EMR137.08-2.47 (-1.77%) ▼|FDX306.94-6.04 (-1.93%) ▼|GD373.71+5.13 (+1.39%) ▲|GE344.60-4.23 (-1.21%) ▼|GEV1,065.93+8.09 (+0.76%) ▲|GILD133.53-0.75 (-0.56%) ▼|GM76.15+0.08 (+0.11%) ▲|GOOG355.32+9.20 (+2.66%) ▲|GOOGL355.56+8.79 (+2.53%) ▲|GS1,060.90-4.32 (-0.41%) ▼|HD333.69-5.18 (-1.53%) ▼|HON227.06+2.04 (+0.91%) ▲|IBM215.02+2.35 (+1.11%) ▲|INTC99.25+4.21 (+4.43%) ▲|INTU292.57+1.48 (+0.51%) ▲|ISRG351.12+5.70 (+1.65%) ▲|JNJ251.11-1.93 (-0.76%) ▼|JPM340.27-0.83 (-0.24%) ▼|KO81.53-0.03 (-0.04%) ▼|LIN513.98+0.76 (+0.15%) ▲|LLY1,167.20-11.92 (-1.01%) ▼|LMT512.63+3.86 (+0.76%) ▲|LOW204.91-3.82 (-1.83%) ▼|LRCX312.30-1.01 (-0.32%) ▼|MA546.40+2.80 (+0.52%) ▲|MCD267.24-0.47 (-0.18%) ▼|MDLZ59.79-1.22 (-1.99%) ▼|MDT83.66+0.46 (+0.55%) ▲|META647.51+1.50 (+0.23%) ▲|MMM160.89+1.05 (+0.66%) ▲|MO74.24+0.03 (+0.04%) ▲|MRK125.68-1.82 (-1.43%) ▼|MS211.96-3.54 (-1.64%) ▼|MSFT400.05+6.23 (+1.58%) ▲|MU899.47+50.52 (+5.95%) ▲|NEE88.12-0.68 (-0.77%) ▼|NFLX67.95-1.00 (-1.45%) ▼|NKE43.36-0.40 (-0.91%) ▼|NOW103.69+0.45 (+0.44%) ▲|NVDA205.66+2.85 (+1.41%) ▲|ORCL122.68-3.73 (-2.95%) ▼|PEP134.92-2.21 (-1.61%) ▼|PFE24.89-0.17 (-0.66%) ▼|PG149.43-0.56 (-0.37%) ▼|PLTR135.23+2.85 (+2.15%) ▲|PM192.02-0.97 (-0.50%) ▼|QCOM172.88+1.10 (+0.64%) ▲|RTX196.71+3.20 (+1.65%) ▲|SBUX106.09+0.60 (+0.57%) ▲|SCHW100.49-1.07 (-1.05%) ▼|SO95.43+0.13 (+0.14%) ▲|SPG230.04+1.34 (+0.59%) ▲|T21.83+0.02 (+0.09%) ▲|TMO526.68-5.81 (-1.09%) ▼|TMUS194.42+1.99 (+1.03%) ▲|TSLA375.30-5.54 (-1.45%) ▼|TXN289.55+5.53 (+1.95%) ▲|UBER72.23-0.23 (-0.32%) ▼|UNH422.09-4.00 (-0.94%) ▼|UNP300.40-1.35 (-0.45%) ▼|UPS113.72-4.00 (-3.40%) ▼|USB63.27+0.13 (+0.21%) ▲|V359.07+0.51 (+0.14%) ▲|VZ43.48-0.12 (-0.26%) ▼|WFC86.96-0.55 (-0.63%) ▼|WMT113.99-0.25 (-0.22%) ▼|XOM148.37+1.01 (+0.68%) ▲|
24.9 C
New York
Monday, July 20, 2026

Tag: MIN

newssourceFORcompanyinformationcontent1releasesmarket

Tineco’s World #1 Floor Cleaner Range Up To 46% Off For Amazon Prime Day

SYDNEY, July 7, 2026 /PRNewswire/ -- Research will be key for Australians heading into Amazon Prime Day this year, hoping to grab a bargain...

Legacy Receives New York State CLEP Approval for Two Laboratory-Developed Tests: Semen Analysis and DNA Fragmentation

Legacy clears New York's stringent pre-market review of laboratory-developed tests for both of its core andrology assays, semen analysis and DNA fragmentation analysis.NEW YORK,...

Vascarta Announces Phase I Results of VAS-101 Administered Sublingually in Sickle Cell Disease Patients

SUMMIT, N.J., June 24, 2026 /PRNewswire/ -- Vascarta Inc., a clinical-stage biopharmaceutical company advancing innovative treatments for pain and inflammation, announced today the successful...

Xiao-I Corporation Provides Update on First-Instance Rulings in Patent Litigation Against Apple; Company Intends to Appeal to the Supreme People’s Court

SHANGHAI, June 19, 2026 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading developer of AI solutions, provided a material update...

Premium Jeju Fruit Spirit “TOMORA” Wins Consecutive Awards at Major Global Spirits Competitions

SEOUL, South Korea, June 15, 2026 /PRNewswire/ -- TOMORA Craft Spirits, a handcrafted premium Jeju mandarin spirit inspired by the ancient name of Jeju's...

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in adults with hypoparathyroidism. Over the three-and-a-half-year duration of the trial, TransCon PTH replicated the systemic actions of endogenous PTH, with a balanced, beneficial impact on the main target organ systems – CNS, kidney, small intestine, and bone – as demonstrated by improved quality of life and normalized and stable urine calcium, serum calcium, serum phosphate, and bone mineral density. These benefits were sustained while enabling independence from conventional therapy with active vitamin D and calcium.

HeroMD 4-MAX Claims Evaluated: Why Men Searching “Most Effective 4-in-1 Erectile Dysfunction Formula” Are Comparing SURGE, PRIME and The HERO System Explained

HeroMD 4-MAX scam or legit? Compounded 4-in-1 sublingual ED formula with 10-min onset and 36-hr window reviewed.

THE 2026 FRAGRANCE FOUNDATION AWARDS BOWS AT LINCOLN CENTER IN NYC FOR THE BIGGEST NIGHT IN AMERICAN FRAGRANCE

Nordstrom, Inc. and Master Perfumer Honorine Blanc Receive Industry's Top Honors-Ceremony Pays Tribute to Legends Lost - Giorgio Armani and Valentino GaravaniNEW YORK, June 11, 2026 /PRNewswire/...

Water Sports Foundation’s Top Tips for Boosting the Fun Factor When Boating with Kids

Experts Share Advice on How to Keep Kids Engaged and Enjoying Family Time on the WaterORLANDO, Fla., June 11, 2026 /PRNewswire/ -- Family boating adventures...

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results
and Provides Business Update

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

The Week in Canadian Press Releases: 10 Stories You Need to See

A roundup of the most newsworthy press releases from Cision Distribution this weekTORONTO, June 5, 2026 /CNW/ - With thousands of press releases published...

Traveloka 6.6 Mid-Year Sale: Flight, Hotel and Attraction Deals from RM66 for Malaysian Travelers

Traveloka's 6.6 Mid-Year Sale: Flights, Hotels and Activities from RM66KUALA LUMPUR, Malaysia, June 4, 2026 /PRNewswire/ -- Traveloka, Southeast Asia's all-in-one travel tech platform,...

CoolIT Systems Demonstrates 15kW Coldplate, Extending Single-Phase DLC Roadmap Far Beyond 2030

The design delivers nearly 4x the capacity of CoolIT's previously demonstrated coldplate, extending the leadership of single-phase direct liquid cooling for multiple generations of...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMIN

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers